Top Markets
Coin of the day
Zhejiang Hisun Pharmaceutical Co., Ltd. Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

600267
Rang in Aktien #6294
Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the... Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical products. Its portfolio includes both active pharmaceutical ingredients (APIs) and finished drug formulations. The company's extensive therapeutic focus spans oncology, cardiovascular health, infectious diseases, liver support, orthopedics, parasitic infections, and immunosuppression. Additionally, Hisun Pharmaceutical addresses conditions such as weight management, viral infections, tuberculosis, and offers veterinary pharmaceuticals, among other specialized medical applications. Beyond its product lines, the firm provides product consultation and contract manufacturing/research (CMO/CRO) services. Established in 1956, Zhejiang Hisun Pharmaceutical Co., Ltd. is headquartered in Taizhou, China.
Aktienkurs
$1.79
Marktkapitalisierung
$2.12B
Veränderung (1 Tag)
0.65%
Veränderung (1 Jahr)
15.95%
Land
CN
Handel Zhejiang Hisun Pharmaceutical Co., Ltd. (600267)

Kategorie

Dividendenrendite-Verlauf für Zhejiang Hisun Pharmaceutical Co., Ltd. (600267)
Dividendenrendite (TTM) von Zhejiang Hisun Pharmaceutical Co., Ltd. (Aktienkürzel: 600267) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber